approval · primary record
ATEZOLIZUMAB AND HYALURONIDASE-TQJS
FDA · BLA · 2026-10-08
| Agency | FDA |
|---|---|
| Submission type | BLA |
| Action date | 2026-10-08 |
| Brand | TECENTRIQ HYBREZA |
| Sponsor | GENENTECH INC |
| Route | INJECTION |
Provenance
- Source: openFDA Drugs@FDA
- Fetched at: 2026-10-28T03:31:15.770Z
- Licence class: public-domain
- Verdict: primary-source
- Entity id: FDA:ATEZOLIZUMAB AND HYALURONIDASE-TQJS:2026-10-08
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.